Clinical trials
Withdrawn Phase 2 trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Taiwan University Hospital | 2 |
| A2 Healthcare Taiwan Corporation | 1 |
| Arbutus Biopharma Corporation | 1 |
| Botanicure Co., Ltd. | 1 |
| Ellipses Pharma | 1 |
| Eucure (Beijing) Biopharma Co., Ltd | 1 |
| Janssen Research & Development, LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Health Research Institutes, Taiwan | 1 |
| PhytoHealth Corporation | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis B, Chronic | 2 |
| Alzheimer Disease | 1 |
| Astrocytoma | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Transitional Cell | 1 |
| Dementia, Vascular | 1 |
| Disease Progression | 1 |
| Ependymoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.